MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Alenami | |
New | APOHealth Anti-inflammatory Pain Relief Tablets | |
New | APOHealth Chloramphenicol | |
New | APX-Diazepam | |
New | APX-Ondansetron | |
New | Asmol CFC-free Inhaler with Counter | |
New | Blooms the Chemist Anti-inflammatory Pain Relief Tablets | |
New | Bortezomib Sandoz | |
New | Bortezomib-Teva | |
New | Chemists' Own Diarrhoea Relief Plus | |
New | Clozitor | |
New | DBL Bortezomib | |
New | Femin | |
New | Glatira | |
New | Glatiramer Acetate-Teva | |
New | Hydromorphone-hameln, Hydromorphone-hameln-HP | |
New | Inflamax Spray | |
New | Ketorolac Kabi | |
New | Lagevrio | |
New | Levoxine | |
New | Libtayo | |
New | Mesalazine 1.2 TAKEDA | |
New | Nitrofurantoin BNM | |
New | Nuvaxovid | |
New | Paradyn | |
New | Paxlovid | |
New | Piqray | |
New | Ultomiris 100 mg/mL | |
New | Uriclense 500 | |
New | Xylonor | |
Revised | Adacel Polio | Shelf Life |
Revised | Adrenaline Jr Viatris | Nature and Contents of Container, Product Name change, Qualitative and Quantitative Composition |
Revised | Adrenaline Viatris | Nature and Contents of Container, Pharmaceutical Form, Product Name change, Qualitative and Quantitative Composition |
Revised | Advagraf XL | List of Excipients, List of Excipients, Nature and Contents of Container, Nature and Contents of Container, Qualitative and Quantitative Composition, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Precautions for Storage |
Revised | Afluria Quad | Qualitative and Quantitative Composition |
Revised | Alphamox | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Amitriptyline Viatris | Product Name change, Qualitative and Quantitative Composition |
Revised | ANSTO Health Sodium Iodide (131I) Injection | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Incompatibilities, List of Excipients, Nature and Contents of Container, New indication, Pharmacological Properties, Physicochemical Properties, Special Precautions for Disposal, Special Warnings and Precautions for Use |
Revised | ANSTO Health Sodium Iodide (131I) Therapy Capsules | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Disposal, Special Warnings and Precautions for Use |
Revised | ANSTO Health Sodium Iodide (131I) Therapy Solution | Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | APO-Citalopram | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Escitalopram | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | APOHealth Cardio Aspirin | Adverse Effects, Dosage and Administration, Indications, Interactions with Other Medicines, Precautions |
Revised | APOHealth Cetirizine Hayfever & Allergy Relief | Adverse Effects (Undesirable Effects), Dosage and Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Tramadol SR | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | APX-Escitalopram | Adverse Effects (Undesirable Effects), Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | APX-Ondansetron ODT | Nature and Contents of Container |
Revised | Aratac | Qualitative and Quantitative Composition |
Revised | Arazil | Nature and Contents of Container, Special Precautions for Storage |
Revised | Aricept | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Aridol | Sponsor |
Revised | Aubagio | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Azithromycin Sandoz | List of Excipients |
Revised | Bavencio | Physicochemical Properties |
Revised | Bexsero | Adverse Effects (Undesirable Effects) |
Revised | Bimatoprost Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Blooms the Chemist Escitalopram | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | BTC Fluoxetine | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation,Reinstated product, Special Warnings and Precautions for Use |
Revised | Carbosorb X | List of Excipients |
Revised | Celecoxib GH | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Cholstat | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Cilamox | Adverse Effects (Undesirable Effects), Interactions with Other Medicines, Nature and Contents of Container, Overdose, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Cipla Imatinib Adult | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Cipramil | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Claratyne | Deleted Presentation, Dosage and Administration, Precautions, Presentation |
Revised | Claratyne (Unscheduled) | Deleted Presentation, New Presentation of Brand already available |
Revised | Claratyne-D with Decongestant Repetabs | Adverse Effects, Interactions with Other Medicines |
Revised | Clindamycin Mylan | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Colofac | Nature and Contents of Container |
Revised | Comirnaty | Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Comirnaty (Tris/Sucrose Presentation) | Dose and Method of Administration, Special Warnings and Precautions for Use, Adverse Effects (Undesirable Effects), Dose and Method of Administration, Shelf Life, Special Warnings and Precautions for Use |
Revised | Cosentyx | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Creon Capsules | Nature and Contents of Container, Pharmaceutical Form |
Revised | Creon Micro | Adverse Effects (Undesirable Effects), Nature and Contents of Container |
Revised | Cresemba | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | CSL Rh(D) Immunoglobulin-VF | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | DBL Glyceryl Trinitrate Concentrate Injection | Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | DBL Pentamidine Isethionate for Injection | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Dexamethasone Mylan | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Deztron | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Physicochemical Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Dilart HCT | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Dilaudid | Nature and Contents of Container |
Revised | Enerzair Breezhaler | Special Precautions for Storage |
Revised | Enlafax-XR | Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | EpiPen | TGA Date |
Revised | EpiPen Jr | TGA Date |
Revised | Ertapenem Kabi | Adverse Effects (Undesirable Effects) |
Revised | Escitalopram Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ethical Nutrients Clinical Nervalgesic | Product Name change, Product Name change |
Revised | Ethical Nutrients Clinical Nervalgesic Muscle | Product Name change, Product Name change |
Revised | Femoston 1/10 | Adverse Effects (Undesirable Effects), Boxed Warnings, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Femoston 2/10 | Adverse Effects (Undesirable Effects), Boxed Warnings, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Femoston-Conti | Adverse Effects (Undesirable Effects), Boxed Warnings, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Fenac | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Nature and Contents of Container, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Fiasp | TGA Date |
Revised | Flagyl | Special Warnings and Precautions for Use |
Revised | Flagyl S Suspension | Special Warnings and Precautions for Use |
Revised | Fluad Quad | List of Excipients, Qualitative and Quantitative Composition |
Revised | Flucelvax Quad | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Fluoxetine APOTEX | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Fluzole | Pharmaceutical Form |
Revised | Gopten | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Hadlima | Adverse Effects (Undesirable Effects) |
Revised | Iberogast | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Imatinib GH | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Precautions for Disposal, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Imovane | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Invanz | Adverse Effects (Undesirable Effects) |
Revised | Istodax | TGA Date |
Revised | Jakavi | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Kanjinti | TGA Date |
Revised | L.C.E. Sandoz | Nature and Contents of Container |
Revised | Lamictal | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Lexapro | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Lipiodol Ultra Fluid | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Loxalate | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Lucentis | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Lumigan PF | Dose and Method of Administration, Special Precautions for Disposal |
Revised | Luvox | Nature and Contents of Container, Pharmaceutical Form |
Revised | Marcain Spinal 0.5%, Marcain Spinal 0.5% Heavy | Special Warnings and Precautions for Use |
Revised | Marcain, Marcain with Adrenaline | Special Warnings and Precautions for Use |
Revised | Menopur | Adverse Effects (Undesirable Effects) |
Revised | Meropenem GH | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Metronide | Special Warnings and Precautions for Use |
Revised | Mircera | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Morphine Sulfate Medsurge | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Movox | Nature and Contents of Container, Pharmaceutical Form |
Revised | Moxicam | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, New contraindication, Special Warnings and Precautions for Use |
Revised | Moxicam Capsules | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, New contraindication, Qualitative and Quantitative Composition |
Revised | Mysoline | Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Nerlynx | Nature and Contents of Container |
Revised | Nucala | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Opdivo | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Oxycodone HCl Medsurge | Pharmacological Properties |
Revised | Pfizer (Australia) Daunorubicin Injection | Fertility, Pregnancy and Lactation |
Revised | Pharmacor Rasagiline | Special Warnings and Precautions for Use |
Revised | Phosphate Phebra | TGA Date |
Revised | Plaquenil | Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Pomalyst | Pharmaceutical Form |
Revised | Posaconazole Sandoz | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Praxbind | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Pro-Banthine | Qualitative and Quantitative Composition, Sponsor |
Revised | Proctosedyl Ointment | Sponsor, Sponsor, TGA Date, TGA Date |
Revised | Proctosedyl Suppositories | Sponsor, Sponsor, TGA Date, TGA Date |
Revised | Prograf | List of Excipients, List of Excipients, Nature and Contents of Container, Nature and Contents of Container, Qualitative and Quantitative Composition, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Precautions for Storage |
Revised | Prolia | Special Warnings and Precautions for Use |
Revised | PYtest | Dose and Method of Administration |
Revised | Quetia | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Quinate | Dose and Method of Administration, Name of Medicine, Qualitative and Quantitative Composition |
Revised | Rasazil | Special Warnings and Precautions for Use |
Revised | Remsima | TGA Date |
Revised | Renflexis | Adverse Effects (Undesirable Effects) |
Revised | Restavit | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Physicochemical Properties, Shelf Life, Special Precautions for Storage |
Revised | Revlimid | TGA Date |
Revised | Ryaltris | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Sandimmun | Deleted Presentation, Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Solicare | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Solifenacin Lupin | TGA Date |
Revised | Solu-Medrol | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients |
Revised | Spironolactone Viatris | Nature and Contents of Container, Product Name change, Qualitative and Quantitative Composition |
Revised | Sporanox Oral Solution | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Sprycel | Adverse Effects (Undesirable Effects) |
Revised | Stemetil | Deleted Presentation, Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Special Precautions for Storage |
Revised | Symtuza | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Tevatiapine XR | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Teveten | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Thalomid | TGA Date |
Revised | Tramadol Sandoz | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Tramadol Sandoz Injection | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Tramadol SR Generichealth | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Tramedo SR | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Trexject | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Uptravi | Adverse Effects (Undesirable Effects) |
Revised | Vancocin Capsules | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Vancomycin AN | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Vaxzevria | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use, Special Precautions for Storage |
Revised | Vidaza | TGA Date |
Revised | Xylocaine 5% Ointment | TGA Date |
Revised | Xylocaine Viscous | TGA Date |
Revised | Zan-Extra | List of Excipients, Nature and Contents of Container |
Revised | Zarontin | List of Excipients, Nature and Contents of Container |
Revised | Zavedos | Adverse Effects (Undesirable Effects), Deleted Presentation, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Overdose, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Zejula | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Zeposia | TGA Date |
Revised | Zithromax | Qualitative and Quantitative Composition |
Revised | Zolgensma | Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Pharmacological Properties, Special Precautions for Disposal |
Revised | Zotren ODT | Nature and Contents of Container |
Revised | Zyban SR | Adverse Effects (Undesirable Effects) |
Deleted | Amiodarone Actavis | |
Deleted | Bosentan Sandoz | |
Deleted | Combigesic | |
Deleted | Demazin Cold and Flu Tablets | |
Deleted | Fortum | |
Deleted | Lax-Sachets | |
Deleted | Maxiclear | |
Deleted | Picato | |
Deleted | Salpraz Heartburn Relief | |
Deleted | Sudafed Sinus 12 Hour Relief Tablets | |
Deleted | Timentin | |
Deleted | Xyloproct |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au